Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1993
10/19/1993US5254343 Applying salt of alpha-hydroxy acid
10/19/1993CA1323374C 2 - furylbutyrolactones
10/19/1993CA1323373C .beta.-d-phenyl-thioxylosides, their method of preparation and their useas therapeutics
10/19/1993CA1323368C 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines
10/19/1993CA1323367C Phenyl-substituted piperidine compounds and their preparation and use in treating calcium overload in brain cells of mammals
10/19/1993CA1323366C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives
10/19/1993CA1323365C Heterocyclic compounds and their preparation and use
10/19/1993CA1323306C Pharmacological agent-lipid solution preparation
10/19/1993CA1323305C Delivery systems for pharmacological agents
10/18/1993CA2094219A1 Stabilized solid pharmaceutical preparation and method of producing the same
10/18/1993CA2094164A1 Arylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing it
10/17/1993CA2094082A1 Substituted azetidinyle pyridone derivatives, antimicrobial agents
10/17/1993CA2094076A1 Indole derivatives
10/17/1993CA2094075A1 Indole derivatives
10/17/1993CA2094073A1 Indole derivatives
10/17/1993CA2093947A1 Propenoyl-imidazole derivatives
10/17/1993CA2092342A1 Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity
10/16/1993CA2094117A1 Tachykinin receptor antagonists, isoquinolones and their production
10/14/1993WO1993020438A1 A nicotine and/or nicotine metabolite detection system
10/14/1993WO1993020221A1 Gene therapy using targeted viral vectors
10/14/1993WO1993020101A1 Inhibitor of protein kinase c
10/14/1993WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993WO1993020097A1 17-substituted steroids useful in cancer treatment
10/14/1993WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus
10/14/1993WO1993020088A1 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
10/14/1993WO1993020086A1 Process for producing derivatives of bis(aminomethyl) phosphinic acid
10/14/1993WO1993020082A1 Calanolide antiviral compounds, compositions and uses thereof
10/14/1993WO1993020080A1 Bridged bis-aryl carbinol derivatives, compositions and methods of use
10/14/1993WO1993020078A1 Pharmaceutically active bicyclic-heterocyclic amines
10/14/1993WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same
10/14/1993WO1993020073A1 Indole derivatives as 5-ht1 agonists
10/14/1993WO1993020072A1 (furan-2-yl)-2-(1-normon-2-yl) oxazole derivatives with antibacterial activity
10/14/1993WO1993020071A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists
10/14/1993WO1993020066A1 Imidazole, triazole and tetrazole derivatives
10/14/1993WO1993020063A1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use
10/14/1993WO1993020062A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists
10/14/1993WO1993020061A1 4-[4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
10/14/1993WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
10/14/1993WO1993020058A1 Novel cardioprotective agents
10/14/1993WO1993020057A1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols
10/14/1993WO1993020056A1 Melamine derivatives for use in the treatment of cancer
10/14/1993WO1993020055A1 Antiproliferative quinazolines
10/14/1993WO1993020052A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
10/14/1993WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors
10/14/1993WO1993020046A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for preparation of same and their use as therapeutic agents
10/14/1993WO1993020045A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for the preparation of same and their application as therapeutic agents
10/14/1993WO1993020044A1 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity
10/14/1993WO1993020036A1 Total synthesis of taxol
10/14/1993WO1993019778A1 Method for inducing tolerance to an antigen using butyrate
10/14/1993WO1993019769A1 Wound healing and treatment of fibrotic disorders
10/14/1993WO1993019768A1 Self-assembling polynucleotide delivery system
10/14/1993WO1993019763A1 Rapamycin formulation for iv injection
10/14/1993WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv)
10/14/1993WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993WO1993019760A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives
10/14/1993WO1993019759A1 Vitamin d derivative feed compositions and methods of use
10/14/1993WO1993019758A1 Compositions and methods for treating benign prostatic hypertrophy
10/14/1993WO1993019757A1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia
10/14/1993WO1993019756A1 The use of quinoline-3-carboxamide compounds for treatment of diabetes
10/14/1993WO1993019755A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness
10/14/1993WO1993019754A1 Phenol and pyridinol derivatives as lusitropic agents
10/14/1993WO1993019753A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans
10/14/1993WO1993019752A1 Inhibition of p70 s6 kinase
10/14/1993WO1993019751A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
10/14/1993WO1993019750A1 Compounds useful for treating allergic or inflammatory diseases
10/14/1993WO1993019749A1 Compounds useful for treating allergic and inflammatory diseases
10/14/1993WO1993019748A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
10/14/1993WO1993019747A1 Compounds useful for treating allergic and inflammatory diseases
10/14/1993WO1993019746A1 Topical administration of toremifene and its metabolites
10/14/1993WO1993019745A1 Method of treating clostridium difficile colitis and cholera
10/14/1993WO1993019744A1 External preparation for curing damage to skin
10/14/1993WO1993019743A1 Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid
10/14/1993WO1993019742A1 Medicament against cardiac circulatory diseases
10/14/1993WO1993019739A1 Viscous suspensions of controlled-release drug particles
10/14/1993WO1993019737A1 A pharmaceutical composition containing a defined lipid system
10/14/1993WO1993019736A1 A pharmaceutical carrier system containing defined lipids
10/14/1993WO1993019730A1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use
10/14/1993WO1993019729A1 Retinoic acid as a skin tanning agent in persons of light skin color
10/14/1993WO1993019720A2 Compounds
10/14/1993WO1993019708A1 Transdermal albuterol absorption dosage unit and process
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/14/1993WO1993015061A3 Method of preparing 2-arylbenzimidazole 5-sulphonic acids
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/14/1993DE4310051A1 Treating allergic rhinitis or conjunctivitis - using 3-substd. 6-(substd. phenyl)-pyridazine deriv., also for treating e.g. nasal polyps
10/14/1993DE4310050A1 Use of sulphonamido:phenyl benzo:naphthyridine - for treating allergic rhinitis or conjunctivitis, and also for treating e.g. nasal polyps
10/14/1993DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists
10/14/1993DE4212250A1 New 1-phenyl:benzyl -benzimidazole derivs. with alkylene-bridged heterocyclic gp. - used as angiotensin II antagonists e.g. for treating cardiovascular, pulmonary or CNS disorders
10/14/1993DE4211878A1 Compsn. for treating multiple sclerosis - comprising protein, peptide or aminoacid with low glycine, glutamine, glutamic acid, arginine and phenylalanine content
10/14/1993DE4211238A1 Topical treatment of skin or mucosal papillomatosis - using 2',5'- oligo:adenylate derivs. having strong activity against episomal papillome viruses
10/14/1993CA2133744A1 1,4 naphthoquinone derivatives with anti-protozoal and anti-parasitic activity
10/14/1993CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity
10/14/1993CA2133470A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness
10/14/1993CA2133461A1 4-[4'piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
10/14/1993CA2133460A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists
10/14/1993CA2133440A1 Compositions and methods for treating benign prostatic hypertrophy
10/14/1993CA2133415A1 A nicotine and/or nicotine metabolite detection system
10/14/1993CA2133411A1 Gene therapy using targeted viral vectors
10/14/1993CA2133193A1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use
10/14/1993CA2133083A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists